References
- XavierRPodolskyDUnravelling the pathogenesis of inflammatory bowel diseaseNature2007448715242743417653185
- PodolskyDKInflammatory bowel diseaseN Engl J Med199132514100810161886623
- BurischJMunkholmPThe epidemiology of inflammatory bowel diseaseScand J Gastroenterol201550894295125687629
- HeadKAJurenkaJSInflammatory bowel disease part I: ulcerative colitis–pathophysiology and conventional and alternative treatment optionsAltern Med Rev20038324728312946238
- FaubionWAJrLoftusEVJrHarmsenWSZinsmeisterARSandbornWJThe natural history of corticosteroid therapy for inflammatory bowel disease: a population-based studyGastroenterology2001121225526011487534
- HanauerSBFeaganBGLichtensteinGRMaintenance infliximab for Crohn’s disease: the ACCENT I randomised trialLancet200235993171541154912047962
- GisbertJPGonzález-LamaYMatéJ5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic reviewInflamm Bowel Dis200713562963817243140
- SchäckeHSchotteliusADöckeW-DDissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effectsProc Natl Acad Sci2004101122723214694204
- DebnathTKimDHLimBONatural products as a source of anti-inflammatory agents associated with inflammatory bowel diseaseMolecules20131867253727023783459
- MadavSTripathiHTandanMishraSAnalgesic, antipyretic and antiulcerogenic effects of andrographolideIndian J Pharm Sci1995573121125
- SinhaJMukhopadhyaySDasNBasuMKTargeting of liposomal andrographolide to L. donovani-infected macrophages in vivoDrug Deliv20007420921311195427
- MelchiorJPalmSWikmanGControlled clinical study of standard-ized Andrographis paniculata extract in common cold – a pilot trialPhytomedicine19973431531823195187
- ShenTYangWSYiY-SAP-1/IRF-3 targeted anti-inflammatory activity of andrographolide isolated from Andrographis paniculataEvid Based Complement Alternat Med2013201321073623840248
- SheejaKShihabPKuttanGAntioxidant and anti-inflammatory activities of the plant Andrographis paniculata NeesImmunopharmacol Immunotoxicol200628112914016684672
- WangJTanXFNguyenVSA quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasisMol Cell Proteomics201413387688624445406
- WasmanSMahmoodAChuaLSAlshawshMAHamdanSAntioxidant and gastroprotective activities of Andrographis paniculata (Hempedu Bumi) in Sprague Dawley ratsIndian J Exp Biol2011491076777222013743
- LiuWGuoWGuoLAndrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 responseInt Immunopharmacol201420233734524704625
- SandbornWJTarganSRByersVSAndrographis paniculata extract (HMPL-004) for active ulcerative colitisAm J Gastroenterol20131081909823044768
- YeLWangTTangLPoor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoproteinJ Pharm Sci2011100115007501721721007
- RenKZhangZLiYPhysicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-β-cyclodextrinPharmazie200964851552019746840
- BothirajaCShindeMBRajalakshmiSPawarAPEvaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide-PVPJ Pharm Pharmacol200961111465147219903371
- SermkaewNKetjindaWBoonmePPhadoongsombutNWiwattanapatapeeRLiquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from a crude extract of Andrographis paniculataEur J Pharm Sci201350345946623973887
- YangTShengHHFengNPWeiHWangZTWangCHPreparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activityJ Pharm Sci2013102124414442524166599
- GutiérrezJGonzálezCMaestroASoleIPeyCNollaJNanoemulsions: new applications and optimization of their preparationCurr Opin Colloid Interface Sci2008134245251
- MadeneAJacquotMScherJDesobrySFlavour encapsulation and controlled release – a reviewInt J Food Sci Technol2006411121
- VyasTKShahiwalaAAmijiMMImproved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulationsInt J Pharm200834719310117651927
- LovelynCAttamaAACurrent state of nanoemulsions in drug deliveryJ Biomater Nanobiotechnol201125A626639
- KottaSKhanAWPramodKAnsariSHSharmaRKAliJExploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugsExpert Opin Drug Deliv20129558559822512597
- VandammeTFAntonNLow-energy nanoemulsification to design veterinary controlled drug delivery devicesInt J Nanomedicine2010586787321042549
- WangXJiangYWangY-WHuangM-THoC-THuangQEnhancing anti-inflammation activity of curcumin through O/W nanoemulsionsFood Chem2008108241942426059118
- LeongTWoosterTKentishSAshokkumarMMinimising oil droplet size using ultrasonic emulsificationUltrason Sonochem200916672172719321375
- QianCMcClementsDJFormation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle sizeFood Hydrocoll201125510001008
- JafariSMHeYBhandariBOptimization of nano-emulsions production by microfluidizationEur Food Res Technol20072255–6733741
- SchultzSWagnerGUrbanKUlrichJHigh-pressure homogenization as a process for emulsion formationChem Eng Technol2004274361368
- BouchemalKBrianconSPerrierEFessiHNano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimizationInt J Pharm20041–2208241251
- FofariaNMQhattalHSSLiuXSrivastavaSKNanoemulsion formulations for anti-cancer agent piplartine – Characterization, toxicological, pharmacokinetics and efficacy studiesInt J Pharm20164981–2122226642946
- TsaiY-MChang-LiaoW-LChienC-FLinL-CTsaiT-HEffects of polymer molecular weight on relative oral bioavailability of curcuminInt J Nanomedicine201272957296622745556
- ChangC-WWangC-YWuY-THsuM-CEnhanced solubility, dissolution, and absorption of lycopene by a solid dispersion technique: the dripping pill delivery systemPowder Technol2016301641648
- YorikiHNaitoYTakagiTHemin ameliorates indomethacin-induced small intestinal injury in mice through the induction of heme oxygenase-1J Gastroenterol Hepatol201328463263823216607
- ImaokaHIshiharaSKazumoriHExacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout miceAm J Physiol Gastrointest Liver Physiol20102992G311G31920508157
- GartiNYaghmurALeserMEClementVWatzkeHJImproved oil solubilization in oil/water food grade microemulsions in the presence of polyols and ethanolJ Agric Food Chem20014952552256211368635
- KommuruTRGurleyBAKhanMReddyIKSelf-emulsifying drug delivery systems (SEDDS) of coenzyme Q 10: formulation development and bioavailability assessmentInt J Pharm2001212223324611165081
- TangSYManickamSWeiTKNashiruBFormulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitationUltrason Sonochem201219233034521835676
- TadrosTIzquierdoPEsquenaJSolansCFormation and stability of nano-emulsionsAdv Colloid Interface Sci2004108–109303318
- ClementeZCastroVLSSMouraMAMJonssonCMFracetoLFToxicity assessment of TiO2 nanoparticles in zebrafish embryos under different exposure conditionsAquat Toxicol201414712913924418748
- FlouryJDesrumauxALardièresJEffect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsionsInnov Food Sci Emerg Technol200012127134
- AzumaKIppoushiKItoHHigashioHTeraoJCombination of lipids and emulsifiers enhances the absorption of orally administered quercetin in ratsJ Agric Food Chem20025061706171211879062
- MonteiroLMLioneVFdo CarmoFADevelopment and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studiesInt J Nanomedicine201275175518223055729
- ShonoYNishiharaHMatsudaYModulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranesJ Pharm Sci200493487788514999725
- dos ReisSBde OliveiraCCAcedoSCAttenuation of colitis injury in rats using Garcinia cambogia extractPhytother Res200923332432918979524
- KotakadiVSJinYHofsethABGinkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosisCarcinogenesis20082991799180618567620
- El-AbharHSHammadLNGawadHSAModulating effect of ginger extract on rats with ulcerative colitisJ Ethnopharmacol2008118336737218571884
- LeeK-CChangH-HChungY-HLeeT-YAndrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathwayJ Ethnopharmacol2011135367868421497192
- Abu-GhefrehAACanatanHEzeamuzieCIIn vitro and in vivo anti-inflammatory effects of andrographolideInt Immunopharmacol20099331331819110075
- XiaY-FYeB-QLiY-DAndrographolide attenuates inflammation by inhibition of NF-κB activation through covalent modification of reduced cysteine 62 of p50J Immunol200417364207421715356172
- SinghUJialalIAnti-inflammatory effects of α-tocopherolAnn N Y Acad Sci20041031119520315753145